Liver siRNA is under clinical development by Nitto BioPharma and currently in Phase II for Liver Cancer. According to GlobalData, Phase II drugs for Liver Cancer have a 31% phase transition success ...
In the field of urology, the rising prevalence of diseases such as urinary stones, infections, and cancers poses significant challenges to public health ...